Cidara Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
185.00
22,796.00
107,514.00
104,619.00
75,314.00
74,562
Total Accounts Receivable
-
-
-
-
321.00
-
Other Current Assets
13.00
217.00
704.00
779.00
2,035.00
2,567
Total Current Assets
198.00
23,013.00
108,218.00
105,398.00
77,670.00
77,129
Net Property, Plant & Equipment
-
863.00
1,684.00
1,374.00
1,044.00
712
Other Assets
3.00
474.00
72.00
190.00
321.00
1,271
Total Assets
201.00
24,350.00
109,974.00
106,962.00
79,035.00
79,112
ST Debt & Current Portion LT Debt
-
-
-
-
2,667.00
Other Current Liabilities
116.00
3,213.00
5,974.00
8,909.00
9,418.00
Total Current Liabilities
116.00
3,213.00
5,974.00
8,909.00
12,085.00
Long-Term Debt
1,483.00
-
-
9,794.00
7,206.00
Other Liabilities
-
34.00
88.00
80.00
-
Total Liabilities
1,599.00
3,247.00
6,062.00
18,783.00
19,291.00
Common Equity (Total)
1,398.00
11,445.00
103,912.00
88,179.00
59,744.00
Total Shareholders' Equity
1,398.00
21,103.00
103,912.00
88,179.00
59,744.00
Total Equity
1,398.00
21,103.00
103,912.00
88,179.00
59,744.00
Liabilities & Shareholders' Equity
201.00
24,350.00
109,974.00
106,962.00
79,035.00
Preferred Stock (Carrying Value)
-
32,548.00
-
-
-
About Cidara Therapeutics
View Profile
